nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2026, 17, v.67 1920-1924
抗肿瘤药物药毒的内涵及其辨治
基金项目(Foundation): 国家自然科学基金(81973737); 第二届全国名中医传承工作室建设项目(国中医药办人教函[2022]245号); 全国名老中医药专家传承工作室建设项目(国中医药人教函[2022]75号); 江苏省名老中医药专家传承工作室建设项目(苏中医科教[2021]7号); 江苏省中医药科技发展计划(ZD202301); 江苏省研究生科研实践创新计划项目(26CXJH3885)
邮箱(Email): zhouhongguang2288@163.com;
DOI: 10.13288/j.11-2166/r.2026.17.019
发布时间: 2026-09-01
出版时间: 2026-09-01
移动端阅读
摘要:

认为抗肿瘤药物属攻毒之品,其峻烈偏性作用于机体后产生继发性病理因素及其病机演变,即药毒。药毒以峻猛伤正、随体从化为基本特点,脏腑受累表现为中焦先应、久及肾髓、旁及五脏,时间维度上呈急性损伤、蓄积损伤与迁延迟发的特点。癌毒、药毒与正虚相互影响,构成动态演变的复合病机格局。临证当以分期为纲、辨毒为目、扶正贯终为总纲,统筹减毒损、祛癌毒与扶正气。同时,须将药毒干预前移,贯穿抗肿瘤治疗全程,为中医药全程参与肿瘤综合治疗提供理论依据。

Abstract:

Antitumor drugs are considered pathogenic toxin-attacking agents,whose intense and biased pharmacological effects on the body may induce secondary pathological factors and subsequent pathological changes,that is,drug toxin.Its pathogenic features include rapid and marked impairment of healthy qi and constitution-dependent transformation.Zang-fu(脏腑) organs involvement is characterized by an early response of the middle jiao(焦),later involvement of the kidney and marrow,and extension to the five zang organs,while its temporal evolution may manifest as acute injury,cumulative injury,and persistent or delayed injury.Cancer toxin,drug toxin,and deficiency of healthy qi interact to form a dynamically evolving complex pathogenic pattern.Clinically,treatment should take disease stage as the framework,toxin differentiation as the focus,and reinforcement of healthy qi as a principle throughout the course,while coordinating toxin reduction and elimination of cancer toxin with reinforcement of healthy qi.Furthermore,intervention against drug toxin should be initiated early and throughout the entire course of antitumor therapy.This framework may provide a theoretical basis for integrating traditional Chinese medicine throughout comprehensive cancer treatment.

参考文献

[1]Jin H, Wang L, Bernards R. Rational combinations of targeted cancer therapies:background, advances and challenges[J]. Nat Rev Drug Discov, 2023, 22(3):213-234.

[2]Basak D, Arrighi S, Darwiche Y, et al. Comparison of anticancer drug toxicities:paradigm shift in adverse effect profile[J]. Life, 2022, 12(1):48.

[3]袁伟琛,周红光,李文婷,等.中医药防治恶性肿瘤的现状、优势及策略[J].南京中医药大学学报,2025, 41(6):707-720.

[4]程海波.癌毒病机理论探讨[J].中医杂志,2014, 55(20):1711-1715.

[5]程海波,李柳,孙东东,等.抗癌解毒法的建立与应用[J].中医杂志,2022, 63(15):1420-1426.

[6]徐思源,李柳,赖岳阳,等.以毒攻毒法论治恶性肿瘤[J].中医杂志,2023, 64(18):1847-1852.

[7]鲁佳敏,孙磊涛,傅钰涵,等.论“扶正解毒”与“解毒复正”辨治恶性肿瘤异同[J].北京中医药大学学报,2023, 46(3):421-426.

[8]李娜,王圆圆,张青.基于“性味归经”理论的顺铂临床性能初探[J].中医杂志,2015,56(21):1822-1825.

[9]刘凌云.由中医“从化”理论谈体质辨证的重要性[J].广州中医药大学学报,2013, 30(1):117-119.

[10]谢伊,周凯男,王妍,等.基于“从化”理论探讨放射性损伤的中医辨治[J].北京中医药大学学报,2023,46(5):639-643.

[11]李浩,邵焱,顾雨甜,等.基于癌毒理论的温滋解毒法辨治化疗相关性骨髓抑制的思路探讨[J].时珍国医国药,2026,37(6):1102-1107.

[12]张国霞,苏鑫,商洪才,等.从“毒损心络”探析肿瘤心脏病的中医病机[J].中医杂志,2022,63(14):1394-1396.

[13]周思瑶,沈洋,杨婕,等.从热毒伤阴探讨免疫检查点抑制剂相关肺炎中医病机及治疗[J].现代中医临床,2025, 32(1):85-88.

[14]邵世梁,焦丽静,王怡超,等.从“火与元气不两立”论治恶性肿瘤免疫检查点抑制剂相关皮肤免疫不良反应[J].中医杂志,2025, 66(16):1656-1661.

[15]程海波,李柳,周学平,等.中医肿瘤癌毒病机辨证体系的创建[J].中医杂志,2020,61(20):1767-1770.

[16]祝金标,卢伟,陈铭昱,等.吴勉华运用合欢花治疗肿瘤并发症经验[J].中医杂志,2025, 66(8):786-789.

[17]周红光.基于一气周流理论探讨温滋解毒法辨治恶性肿瘤[J].南京中医药大学学报,2026, 42(4):543-550.

[18]王逸君,张碧云,于大海,等.益髓健脾汤防治直肠癌患者新辅助同期放化疗骨髓抑制的临床研究[J].南京中医药大学学报,2018, 34(6):557-560.

[19]邢丽菊,吴疆,汤伟,等.补肾升白方对乳腺癌术后EC方案化疗后骨髓抑制相关指标影响[J].山东中医杂志,2025, 44(11):1226-1231.

基本信息:

DOI:10.13288/j.11-2166/r.2026.17.019

中图分类号:R273

引用信息:

[1]李浩,周红光,袁伟琛,等.抗肿瘤药物药毒的内涵及其辨治[J].中医杂志,2026,67(17):1920-1924.DOI:10.13288/j.11-2166/r.2026.17.019.

基金信息:

国家自然科学基金(81973737); 第二届全国名中医传承工作室建设项目(国中医药办人教函[2022]245号); 全国名老中医药专家传承工作室建设项目(国中医药人教函[2022]75号); 江苏省名老中医药专家传承工作室建设项目(苏中医科教[2021]7号); 江苏省中医药科技发展计划(ZD202301); 江苏省研究生科研实践创新计划项目(26CXJH3885)

发布时间:

2026-09-01

出版时间:

2026-09-01

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文